Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
54 studies found for:    Open Studies | "Sarcoma, Ewing's"
Show Display Options
Rank Status Study
21 Recruiting Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer
Conditions: Cancer;   Toxicity Due to Chemotherapy;   Sarcoma;   Osteosarcoma;   Lymphoma;   Ewing Sarcoma
Intervention: Drug: Triptorelin (GnRHa) + Chemotherapy
22 Recruiting HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors
Conditions: Rhabdomyosarcoma;   Neuroblastoma;   Sarcoma;   Sarcoma, Ewing;   Osteosarcoma
Interventions: Drug: Doxorubicin HCl liposomal injection;   Device: Philips Sonalleve MR-HIFU Hyperthermia
23 Recruiting Phase 1 Study of MM-398 Plus Cyclophosphamide in Pediatric Solid Tumors
Conditions: Recurrent or Refractory Solid Tumors;   Ewing Sarcoma;   Rhabdomyosarcoma;   Neuroblastoma;   Osteosarcoma
Intervention: Drug: MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
24 Recruiting Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas
Conditions: Sarcoma, Bone;   Sarcoma, Soft Tissue;   Osteosarcoma;   Sarcoma, Ewing;   Rhabdomyosarcoma;   Non-rhabdomyosarcoma Soft-tissue Sarcoma
Intervention: Device: Diffusion Weighted Magnetic Resonance Imaging
25 Recruiting Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors
Conditions: Ewing Sarcoma;   Neuroblastoma;   Rhabdomyosarcoma;   Osteosarcoma;   CNS Tumors
Interventions: Procedure: Allogeneic HCT;   Drug: Donor NK Cell Infusion
26 Recruiting SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing Sarcomas
Conditions: Liposarcoma;   Osteogenic Sarcoma;   Ewing/Ewing-like Sarcoma
Interventions: Drug: Regorafenib;   Drug: Placebo
27 Not yet recruiting QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma
Condition: Clear Cell Sarcoma
Intervention: Drug: AMG 337
28 Recruiting Advanced MR Imaging in Sarcoma Patients
Condition: Sarcoma
Intervention:
29 Recruiting To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
Conditions: Neuroblastoma;   Rhabdomyosarcoma;   Ewing's Sarcoma;   Ewing's Tumor;   Sarcoma, Ewing's;   Sarcomas, Epitheliod;   Sarcoma, Soft Tissue;   Sarcoma, Spindle Cell;   Melanoma;   Malignant Melanoma;   Clinical Oncology;   Oncology, Medical;   Pediatrics, Osteosarcoma;   Osteogenic Sarcoma;   Osteosarcoma Tumor;   Sarcoma, Osteogenic;   Tumors;   Cancer;   Neoplasia;   Neoplasm;   Histiocytoma;   Fibrosarcoma;   Dermatofibrosarcoma
Intervention: Drug: nab-paclitaxel
30 Recruiting Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors
Conditions: Neuroblastoma;   Rhabdomyosarcoma;   Osteosarcoma;   Ewing Sarcoma;   Wilms Tumor;   Desmoplastic Small Round Cell Tumor
Intervention: Drug: Enoblituzumab
31 Not yet recruiting Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Conditions: Adrenal Cortex Carcinoma;   Adult Alveolar Soft Part Sarcoma;   Adult Clear Cell Sarcoma of Soft Parts;   Adult Hepatocellular Carcinoma;   Adult Rhabdomyosarcoma;   Adult Soft Tissue Sarcoma;   Childhood Alveolar Soft Part Sarcoma;   Childhood Central Nervous System Neoplasm;   Childhood Clear Cell Sarcoma of Soft Parts;   Childhood Hepatocellular Carcinoma;   Childhood Rhabdomyosarcoma;   Childhood Soft Tissue Sarcoma;   Childhood Solid Neoplasm;   Ewing Sarcoma;   Hepatoblastoma;   Hepatocellular Carcinoma;   Recurrent Adrenal Cortex Carcinoma;   Recurrent Adult Hepatocellular Carcinoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Alveolar Soft Part Sarcoma;   Recurrent Childhood Central Nervous System Neoplasm;   Recurrent Childhood Hepatocellular Carcinoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma;   Recurrent Hepatoblastoma;   Recurrent Malignant Solid Neoplasm;   Recurrent Renal Cell Carcinoma;   Recurrent Rhabdomyosarcoma;   Renal Cell Carcinoma;   Thyroid Gland Medullary Carcinoma;   Wilms Tumor
Interventions: Drug: Cabozantinib S-malate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
32 Recruiting Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors
Conditions: Glioma;   Neuroectodermal Tumors, Primitive;   Wilms Tumor;   Rhabdomyosarcoma;   Sarcoma, Ewing;   Osteosarcoma;   Retinoblastoma
Interventions: Drug: Metronomic Cyclophosphamide;   Drug: Thalidomide
33 Not yet recruiting A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma
Conditions: Soft Tissue Sarcoma;   Bone Sarcoma;   Chondrosarcoma;   Gastrointestinal Stromal Sarcoma;   Ewing's Tumor Metastatic;   Ewing's Tumor Recurrent;   Osteosarcoma;   Desmoplastic Small Round Cell Tumor
Interventions: Drug: Ipilimumab;   Drug: Nivolumab
34 Recruiting MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
Conditions: Relapsed Pediatric Solid Tumors;   Refractory Pediatric Solid Tumors;   Tumors Located in Bone or Soft Tissue in Close Proximity to Bone;   Rhabdomyosarcoma;   Ewing Sarcoma;   Osteosarcoma;   Neuroblastoma;   Wilms Tumor;   Hepatic Tumor;   Germ Cell Tumor
Intervention: Device: Magnetic Resonance High Intensity Focused Ultrasound
35 Recruiting A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
Conditions: Pediatric Cancer;   Solid Tumors;   Rhabdomyosarcoma;   Ewing Sarcoma;   Soft Tissue Sarcomas;   Osteosarcoma;   Neuroblastoma;   Wilms Tumor;   Hepatic Tumor;   Germ Cell Tumors
Interventions: Device: Magnetic resonance high intensity focused ultrasound;   Drug: Lyso-thermosensitive liposomal doxorubicin
36 Recruiting A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
Conditions: Ewing Sarcoma;   Gastrointestinal Tumor;   Germ Cell Tumor;   Hepatic Tumor;   Lymphoma;   Wilms Tumor;   Rhabdoid Tumor;   Clear Cell Carcinoma;   Renal Cell Carcinoma;   Melanoma;   Neuroblastoma;   Rhabdomyosarcoma;   Non-rhabdomyosarcoma
Interventions: Drug: alemtuzumab;   Drug: fludarabine;   Drug: sirolimus;   Drug: Busulfan;   Drug: melphalan;   Biological: stem cells;   Device: CliniMACS
37 Recruiting Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
Conditions: Bone Cancer;   Chondrosarcoma;   Ewing's Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma;   Bone Necrosis;   Bone Sarcoma;   Osteomyelitis
Interventions: Drug: Feraheme;   Procedure: MR Scan
38 Recruiting HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
Conditions: Rhabdomyosarcoma;   Osteosarcoma;   Ewing Sarcoma;   Soft Tissue Sarcoma;   Neuroblastoma;   Wilms Tumor;   Malignant Peripheral Nerve Sheath Tumor;   Clival Chordoma;   Non-CNS Solid Tumors
Intervention: Biological: HSV1716
39 Recruiting Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
Conditions: Lymphoma;   Childhood Lymphoma;   Solid Tumor;   Childhood Solid Tumor;   Neuroblastoma;   Ewing Sarcoma;   Hodgkin Lymphoma;   Non-Hodgkin Lymphoma;   Rhabdomyosarcoma;   Soft Tissue Sarcoma;   Medulloblastoma;   Germ Cell Tumor;   Wilms Tumor;   Brain Neoplasms;   Medulloblastoma, Childhood;   Neuroectodermal Tumors, Primitive
Interventions: Drug: Genistein;   Drug: Placebo
40 Recruiting TCRαβ+/CD19+ Depleted Haploidentical HSCT + Zoledronate
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Hodgkin Lymphoma;   Non-Hodgkin Lymphoma;   Myelodysplastic Syndrome;   Myeloproliferative Syndrome;   Rhabdomyosarcoma;   Ewing Sarcoma;   Primitive Neuroectodermal Tumor;   Osteosarcoma;   Neuroblastoma
Interventions: Procedure: TCRαβ+/CD19+ depleted Haploidentical HSCT;   Drug: Zoledronate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-54) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.